ORIGINAl PAPERS - Advances in Clinical and Experimental Medicine
Transkrypt
ORIGINAl PAPERS - Advances in Clinical and Experimental Medicine
orIginal papers Adv Clin Exp Med 2011, 20, 5, 613–621 ISSN 1230-025X © Copyright by Wroclaw Medical University Ayten Saracoglu1, Kemal T. Saracoglu1, Mustafa Deniz2, Feriha Ercan3, Yunus Yavuz4, Yılmaz Gogus1 Dopamine – a Preventive Agent for Mesenteric Ischemia and Reperfusion Injury in Abdominal Compartment Syndrome Dopamina – czynnik ochronny przed niedokrwieniem krezki i uszkodzeniem reperfuzyjnym w zespole ciasnoty śródbrzusznej Department of Anesthesiology and Reanimation, Marmara University School of Medicine, Istanbul, Turkey Department of Physiology, Onsekiz Mart University School of Medicine, Canakkale, Turkey 3 Department of Histology and Embriology, Marmara University School of Medicine, Istanbul, Turkey 4 Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey 1 2 Abstract Objectives. Acutely increased intra-abdominal pressure (IAP) may lead to abdominal compartment syndrome (ACS) and multiple organ failure. In a prospective randomized way, the effect of dopamine infusion (3 μg/kg/ min) on mesenteric perfusion, cytokine levels and intestinal histopathological changes were studied in the presence of ACS. Material and Methods. The study involved 28 male Sprague Dawley rats randomly assigned to four groups (n = 7). The external jugular vein was cannulated for infusions. In group 1, before increasing IAP, a 60-minute infusion of dopamine was performed; following this, IAP was raised and the dopamine infusion was continued for another 60 minutes. In group 2 an IAP of 20 mm Hg was maintained for 60 minutes by air insufflation. In group 3, a dopamine infusion was performed simultaneously with an IAP of 20 mm Hg for 60 minutes. Group 4 was the control. Following this phase, midline laparatomy and superior mesenteric artery (SMA) dissection was carried out in all groups and SMA perfusion was measured continuously for 30 minutes with a Doppler probe. Myeloperoxidase (MPO) activity, lipid peroxidation and glutathione (GSH) levels were measured in tissue samples and histopathological scoring was carried out. Results. The results demonstrated that SMA blood flow was increased in Group 1 and Group 3 (100.77 ± 2.94 and 93.82 ± 4.91 mm Hg, respectively) but decreased significantly in Group 2 (74.23 ± 3.01 mm Hg; p < 0.01). Intestinal tissue malondialdehyde (MDA) levels (24.03 ± 2.75 nmol/g) and MPO activity (260.5 ± 11 u/g) were elevated in Group 2; histological scores were elevated in all groups (p < 0.05); and GSH levels were reduced in Group 2 (0.58 ± 0.24 µmol/g; p < 0.01). Conclusions. The results indicated that high IAP causes oxidative organ damage and that dopamine may lessen reperfusion-induced oxidative damage by reducing splanchnic perfusion and controlling the reperfusion of the intra-abdominal organs (Adv Clin Exp Med 2011, 20, 5, 613–621). Key words: abdominal compartment syndrome, ischemia/reperfusion, superior mesenteric artery, blood flow, dopamine. Streszczenie Cel pracy. Bardzo podwyższone ciśnienie śródbrzuszne (IAP) może prowadzić do zespołu ciasnoty śródbrzusznej (ACS) i niewydolności wielonarządowej. W prospektywnym randomizowanym badaniu oceniono wpływ wlewu dopaminy (3 μg/kg/min) na perfuzję krezki, stężenie cytokin i histopatologiczne uszkodzenia jelit w obecności ACS. Materiał i metody. Do badań włączono 28 samców szczurów Sprague Dawley, które przydzielono losowo do czterech grup (n = 7). Przez zewnętrzną żyłę szyjną wprowadzono kaniulę do infuzji. W grupie 1 przed zwiększeniem IAP przeprowadzono 60-minutową infuzję dopaminy, potem zwiększono IAP i kontynuowano wlew dopaminy przez kolejne 60 min. W grupie 2 IAP utrzymywano 20 mm Hg IAP przez 60 min za pomocą wdmuchiwania 614 A. Saracoglu et al. powietrza. W grupie 3 wlew dopaminy był prowadzony jednocześnie z 20 mm Hg IAP przez 60 min. Grupa 4 była kontrolna. Po tej fazie wykonano laparatomię w linii środkowej i wycięcie tętnicy krezkowej górnej (SMA) we wszystkich grupach. Za pomocą sondy Dopplera zmierzono perfuzję SMA w sposób ciągły przez 30 min. Oceniono aktywność mieloperoksydazy (MPO), peroksydację lipidów oraz stężenie glutationu (GSH) w próbkach tkanek i nadano histopatologiczną punktację. Wyniki. Badanie wykazało, że przepływ krwi przez SMA był zwiększony w grupie 1 i grupie 3 (100,77 ± 2,94 i 93,82 ± 4,91 mm Hg), ale zmniejszył się znacząco w grupie 2 (74,23 ± 3,01 mm Hg, p < 0,01). Stężenie malondialdehydu (MDA) (24,03 ± 2,75 nmol/g) i aktywność MPO (260,5 ± 11 U/g) były zwiększone w tkankach jelit w grupie 2; histologiczna punktacja była większa w wszystkich grupach (p < 0,05), a stężenie GSH zmniejszyło się w grupie 2 (0,58 ± 0,24 mmol/g, p < 0,01). Wnioski. Badania wykazały, że duże IAP powoduje oksydacyjne uszkodzenie narządów i że dopamina może zmniejszyć uszkodzenie oksydacyjne wywołane przez reperfuzję, ograniczając perfuzję trzewną i reperfuzję narządów jamy brzusznej (Adv Clin Exp Med 2011, 20, 5, 613–621). Słowa kluczowe: zespół ciasnoty śródbrzusznej, niedokrwienie/reperfuzja, tętnica krezkowa górna, przepływ krwi, dopamina. Intra-abdominal pressure (IAP) can be acutely increased by a variety of causes, including major trauma or abdominal surgery [1]. Pathophysiological changes begin when IAP reaches levels higher than 8 mm Hg [2]. When IAP reaches a critical level (above approximately 15 mm Hg) it can cause fatal multiple organ failure, known as ACS [3]. When it reaches 20 mm Hg, mesenteric blood flow decreases to 70% of its basal value; at 40 mm Hg, blood flow decreases to 30% of normal [4]. The detrimental effects of raised IAP and ACS on the cardiac, pulmonary, hepatic and renal systems are well known and easy to detect clinically [5]. High venous resistance plays a major role in the pathogenesis of ACS [6]. Early abdominal decompression has beneficial results for organ dysfunction and can improve survival in critically ill patients, but it can also cause additional ischemia-reperfusion (I/R) injury and seriously increase morbidity. As Kaçmaz et al. pointed out, reperfusion of ischemic tissue has harmful effects on cellular functions by activating the various reactive oxygen metabolites [7]. Free oxygen radicals are formed by lipid peroxidation and cause the destruction of cell membranes. Various chemicals and I/R injury produce reactive oxygen radicals and these products promote microvascular disturbances [8]. Polymorphonuclear leukocyte infiltration activates chemotactic mediators in tissue and results in acute inflammation [9]. Antioxidant compounds contribute to protecting cells and tissues against the harmful effects of I/R injury [10, 11]. Low-dose dopamine acts as an inotropic agent and also augments superior mesenteric artery (SMA) blood flow [12]. Dopamine has a dose-dependent effect on several specific receptors, producing a pharmacological response [13]. Low-dose dopamine infusion (3 to 5 μg/kg/ /min) activates β1- and β2-adrenergic receptors. This experimental study was undertaken to determine the effects of low-dose dopamine infusion on intestinal blood flow and in the prevention and treatment of I/R injury. Material and Methods The Animals The experiment was carried out on 28 male Sprague Dawley rats (200–250 g) randomly assigned to four groups (n = 7). All experimental protocols were approved by the Marmara University School of Medicine Animal Care and Use Committee. The animals were housed in an air-conditioned room with 12-hour light/dark cycles, where the temperature (22 ± 2°C) and relative humidity (65–70%) were kept constant. The animals were fasted overnight; then, under 1.2 g/kg intraperitoneal urathane anesthesia, tracheotomies were performed to facilitate breathing. The right carotid artery was cannulated to record arterial pressure (using a Nihon Kohden polygraph, model AP-621G). The right jugular vein was also cannulated for the injection of saline or dopamine. A thermometer was inserted into the rectum and the body temperature was maintained at 37°C with a heating pad. A 24 g polymer catheter (0.7 mm × 14 mm) was then inserted intraperioneally. In Groups 1, 2 and 3, using an aneroid sphygmomanometer connected to the catheter, IAP was increased until the aneroid gauge measured 20 mm Hg, and the pressure was maintained for one hour to induce ACS. The animals in Group 1 received a 3 μg/kg/min dopamine infusion both before and during the procedure; Group 2 received a saline solution during the procedure; Group 3 received a dopamine infusion during the procedure. The control group (Group 4) had normal IAP. After inducing ACS, surgical decompression of the abdomen and measurement of SMA blood flow were performed for 30 minutes. At the end of the blood flow measurement, the rats were decapitated. Small intestine (jejunum) tissue samples were removed for the determination of tissue MDA, GSH and MPO levels. Histological damage was scored using the criteria of Ho-Lam Chung et al. [14], which as- 615 Dopamine in Abdominal Compartment Syndrome sess the inflammatory infiltrate (maximum score = 3) and tissue damage (maximum score = 3). Blood Flow Measurements SMA blood flow was measured using the ultrasonic transit time technique [15]. A 0.7 VB 156 probe (Transonics Systems, Ithaca, NY) was used. The probe has two ultrasonic transducers and a fixed acoustic reflector. A 5 mm section of the SMA was isolated for flow probe placement. All fatty tissue was removed from the isolated segment of the vessel to avoid obstruction of the ultrasonic signal. A flow meter (Transonic Systems, model T106) was used to estimate the volume of blood flow, which is expressed in milliliters per minute per 100 g of tissue. Mean arterial pressure (MAP) was recorded simultaneously through a catheter inserted into the carotid artery (Nihon Kohden multichannel recorder, model AP-621G). The resistance of the renal artery (expressed as mm Hg/ /ml/min/100 g) was calculated by dividing the MAP (in millimeters of mercury) by the blood flow. Myeloperoxidase Activity The tissue samples were stored at –80°C for subsequent measurement of myeloperoxidase activity (MPO). The tissue samples were homogenized in 10 cc of ice-cold potassium phosphate buffer (20 mM K2HPO4, pH 6,0). The homogenate was centrifuged at 12,000 rpm for 10 minutes at 4°C, and the supernatant was discarded. The pellet was then rehomogenized with an equivalent volume of 50 mM K2HPO4 containing 0.5% hexadecyltrimethylammonium hydroxide. MPO activity was assessed by measuring the H2O2-dependent oxidation of o-dianisidine 2HCl. One unit of enzyme activity is defined as the amount of MPO that causes a change in absorbance of 1.0/min at 460 nm and 37°C [16]. Malondialdehyde and Glutathione Assays Tissue samples were homogenized in 10 cc of ice-cold 10% trichloracetic acid and centrifuged at 3000 rpm for 15 minutes at 4°C. The supernatant was removed and recentrifuged at 10,000 rpm at 4°C for 8 minutes. The supernatant was transferred to a test tube containing an equal volume of 0.67% TBA; this mixture was then heated to 90°C and maintained at that temperature for 15 minutes. The MDA concentration for each specimen was determined in a spectrophotometer based on the level of absorbance at 532 nm, and was ex- pressed as nmol/g tissue [17]. GSH measurements were performed using a modification of the Ellman procedure [18]. Briefly, after centrifugation at 3000 rpm for 10 minutes, 0.5 ml of the supernatant was added to 2 ml of 0.3 mol/l Na2HPO4 2H2O solution. A 0.2 ml solution of dithiobisnitrobenzoate (0.4 mg/ml, 1% sodium citrate) was added and the absorbance at 412 nm was measured immediately after mixing. GSH levels were calculated using an extinction coefficient of 1.36 × 105 M/cm. The results were expressed in µmol GSH/g tissue. Histological Analysis For light microscopic investigations, intestinal tissues were fixed in 10% formaldehyde, dehydrated in increasing alcohol series, cleared in toluene and embedding in paraffin. Paraffin sections (5 µm) were stained with hematoxylin and eosin (H&E) and examined under a photomicroscope (Olympus BX51, Tokyo, Japan) by an experienced histologist for “blind” characterization of histopathological changes. Statistics All values are presented as means ± SE. Groups of data were compared with using ANOVA followed by Tukey’s multiple comparison test. Differences were considered statistically significant if p < 0.05. Results Blood Flow and Resistance Intestinal artery blood flow values were significantly lower in the groups with ACS than in the control group (p < 0.01, Fig. 1a). The blood flow was significantly improved by dopamine in both Group 1 and Group 3 (p < 0.01). Similar results were noted in the vascular resistance data (Fig. 1b), in which SMA resistance was significantly normalized by dopamine infusion. In the saline-treated ACS group (Group 2) there was no significant change in MAP compared to the control group (Table 1). The MAP was 100.77 ± 2.94 mm Hg in Group 1, 74.23 ± 3 mm Hg in Group 2, 93.82 ± 4.91 mm Hg in Group 3 and 87.5 ± 10.32 mm Hg in the control group. Myeloperoxidase Activity MPO activity, which is accepted as an indicator of neutrophil infiltration, was significantly elevated in the small intestines of Group 2 animals: 616 A. Saracoglu et al. Fig. 1. Changes in a) superior mesenteric artery blood flow and b) resistance. Values are mean: *p < 0.05, **p < 0.01 Ryc. 1. Zmiany w a) przepływie krwi przez tętnicę krezkową górną i b) oporze naczyniowym. Wartości średnie: * p < 0,05; ** p < 0,01 Table 1. Mean arterial pressure Tabela 1. Średnie ciśnienie tętnicze MAP (mm Hg) Group 1* (Grupa 1 ) Group 2 (Grupa 2) Group 3* (Grupa 3) Group 4 (Grupa 4) 100.77 ± 2.94 74.23 ± 3.01 93.82 ± 4.91 87.5 ± 10.32 * p < 0.05 compared with the control group. * p < 0,05 w porównaniu z grupą kontrolną. 260.5 ± 11 U/g, as compared to 172.9 ± 8.85 U/g in the control group (p < 0.001; Fig. 2a). Treatment with dopamine reversed these elevations in the intestinal tissue: The MPO activity in Group 1 was 174.9 ± 10.83 and in Group 3 it was 11.43 ± 15.88. Malondialdehyde Levels MDA levels, an index of lipid peroxidation, were significantly elevated in the intestinal tissue (24.038 ± 2.75 nmol/g) in Group 2, as compared to 17.53 ± 0.89 nmol/g in the control group (p < < 0.05). Dopamine treatment significantly decreased the ACS induced elevation in intestinal MDA levels (Group 1: 17.37 ± 1.78 nmol/g; Group 3: 15.37 ± 2 nmol/g; p < 0.05; Fig. 2b). Glutathione Levels GSH levels in intestinal tissue decreased significantly when IAP was elevated in Group 2 (0.58 ± 0.24 μmol/g) as compared to the control group (1.29 ± 0.09 μmol/g) (p < 0.001). Dopamine treatment significantly preserved GSH levels (Group 1: 1.35 ± 0.13; Group 3: 0.95 ± 0.03 μmol/g; p < 0.01 and p < 0.001 respectively, compared to Group 2; Fig. 2c). 617 Dopamine in Abdominal Compartment Syndrome Fig. 2. a) Myeloperoxidase activity, b) malondialdehyde level and c) glutathione level in the small intestine: *p < 0.05, **p < 0.01 Ryc. 2. a) Aktywność mieloperoksydazy, b) stężenie malondialdehydu i c) glutationu w jelicie cienkim: *p < 0,05; **p < 0,01 Histological Score Light microscopic evaluation revealed that the ACS-induced microscopic damage score in intestinal tissues was very high (2.97 ± 0.028) in comparison with the control tissue (1.023 ± 0.1; p < 0,001; Fig. 3). However, in the dopaminetreated ACS groups the scores were significantly lower than in the saline-treated ACS group (1.97 ± 0.26 in Group 1 and 1.49 ± 0.13 in Group 3; p < < 0.001 and p < 0.01, respectively). Regular intestinal morphology with orderly villus and glands was observed in light microscopic evaluation of the control group (Fig. 4a). In Group 2, severe vascular congestion, spilled epithelium, damaged glands with severe inflammatory cell infiltration, leukocytes and vasocongestion were observed (Fig. 4b–c). On the other hand, the morphologically demonstrated degeneration of the intestinal tissues of the rats was clearly improved when the animals were treated with dopamine infusion. Improved epithelium and improved glandular construction were observed in Group 1 (Fig. 4d). Regular epithelial structure, reduced edema of the lamina propria and improved glandular structure were observed in Group 3 (Fig. 5). Discussion In the pathophysiology of ACS, oxidative tissue injury has an important role, through increased lipid peroxidation and decreased levels of GSH [19]. MPO activity and small intestinal blood flow are also indicators. Paralleling Şener et al.’s results with melatonin [19], the current study indicated that dopamine protects against the oxida- 618 A. Saracoglu et al. Fig. 3. Microscopic damage scores in the small intestine. ***p < 0.01, **p < 0.01 compared with the control group; +++p < 0.01 ++p < 0.01 compared with group 2 Ryc. 3. Mikroskopowa ocena uszkodzeń w jelicie cienkim. ***p < 0,01; **p < 0,01 w porównaniu z grupą kontrolną +++p < 0,01 + +p < 0,01 w porównaniu z grupą 2 Fig. 4. a) Intestinal tissue sample from the control group. Orderly villus (arrows) and glandular tissue (*), HE, × 100 magnification; b) intestinal tissue sample from group 2; spilled epithelium (arrows) and damaged gland (*), HE, × 100 magnification; c) ACS without dopamine treatment; cell increments after intense epithelium spilling (**), damaged epithelium (arrows), leukocytes (arrowhead) vasocongestion (v) HE, × 200 and × 400 magnification; d) intestinal tissue sample from group 1: improved epithelium (arrow), improved glandular structure (*), occasional leukocytes (arrow in inset), HE, × 100 and × 400 magnification Ryc. 4. a) Próbki tkanki jelit z grupy kontrolnej; kosmki (strzałki) i tkanka gruczołowa (*), HE, powiększenie 100 ×; b) próbki tkanki jelit z grupy 2; rozlany nabłonek (strzałki) i uszkodzony gruczoł (*), HE, powiększenie 100 ×; c) ACS bez leczenia dopaminą; odstępy między komórkami po intensywnym rozlaniu nabłonka (**), uszkodzony nabłonek (strzałki), leukocyty (strzałki) przekrwienie (v) HE, powiększenie 200 × i 400 ×; d) próbki tkanki jelit z grupy 1: prawidłowy nabłonek (strzałka), poprawa struktury gruczołowej (*), sporadyczne leukocyty (strzałka we wstawce), HE, powiększenie 100 × i 400 × tive injury caused by ACS. In addition, impaired intestinal blood flow was ameliorated by treatment with low-dose dopamine before and/or during the induction of ACS. IAP can be acutely increased by a variety of causes: major trauma, abdominal surgery, tense ascites, abdominal hemorrhage, intestinal obstruction, large abdominal tumors, peritoneal dialysis, gas insufflation during laparoscopic surgery [20, 21]. Normal IAP for healthy adults is between 0 and 5 mm Hg; it changes from 5 to 7 mm Hg for critically ill patients. Pathological changes in cell components begin when IAP rises above 8 mm Hg. The World Society of Abdominal Compartment Syndrome (WSACS) defines intra-abdominal hypertension (IAH) as sustained or repeated pathologic elevation of IAP greater than 12 mm Hg [22, 23]. High IAP levels reduce the blood flow to all abdominal viscera, but the adrenal glands seem to be protected in experimental studies [24]. This effect is related to venous occlusion in the mesenteric Dopamine in Abdominal Compartment Syndrome Fig. 5. Intestinal tissue sample from Group 3. Regular epithelial structure (arrow), reduced edema of the lamina propria (*), improved intestinal villi structure (* in inset) and occasional leukocytes (arrow in inset), HE, × 200 and × 400 magnification Ryc. 5. Próbki tkanki jelit z grupy 3. Typowa struktura nabłonka (strzałka), zmniejszenie obrzęków blaszki właściwej (*), poprawa struktury kosmków jelitowych (* we wstawce) i sporadyczne leukocyty (strzałka we wstawce), HE, powiększenie 200 × i 400 × region, so that bowel wall edema occurs and IAH becomes more aggravated [25]. Severe intestinal ischemia has a destructive effect on the function and structure of the cardiovascular, pulmonary and renal systems [26]. Barnes et al. [27] demonstrated that as IAP was increased to 40 mm Hg, there was a 36% reduction in cardiac output, with even greater reductions in blood flow in the celiac artery (42%), superior mesenteric artery (61%) and renal arteries (70%). Similarly, Diebel et al. [28] reported that IAH significantly reduces blood flow in the hepatic artery, mesenteric artery and portal vein, and finally causes severe intestinal ischemia, without any change in MAP or cardiac output. A continuous IAP of 20 mm Hg for one hour was found to be the cause of intestinal barrier dysfunction and bacterial translocation in rats [29]. The translocation of bacteria and toxins through the intestinal mucosa causes systemic inflammation and leads to death via multiple organ failure syndrome and in critically ill patients [30]. Treating IAP with decompression may also cause serious problems like I/R injury. Intestinal damage increases further during reperfusion due to an increase in reactive oxygen radicals and endogenous antioxidant defense mechanisms [31]. Dopamine stimulates dopamineric (D1 and D2) and adrenergic (α and β) receptors. It facilitates direct vasodilation by D2 receptor activation. The effects via dopaminergic α and β receptors are dose-dependent and reflect the pharmacology of low-dose dopamine [32] Stimulation of the β-receptor may result in increased cardiac output, 619 whereas stimulation of the α-receptor may increase perfusion pressure by activation of D1 and D2 receptors [33]. At doses of 3 μg/kg/min, dopamine has been found to activate D1 receptors, which causes vasodilation [34]. Dopamine infusions of 3 to 5 μg/kg/min increase cardiac output by producing a positive inotropic effect, following the activation of β1 and β2 adrenergic receptors [13]. Dopamine has also been reported to increase mesenterial blood flow via D1 receptor activation. This is similar to the mechanism of renal blood flow autoregulation [35]. Administering a selective vasodilating drug that increases blood flow to the renal and splanchnic regions is an alternative treatment method in ACS when surgical procedures are insufficient [36]. Dopamine seems to be the best agent, since it affects all adrenergic receptor types. β adrenergic effects are predominant during low-dose dopamine infusion. On the other hand, the vasodilatory effects are camouflaged by D1 adrenergic receptor stimulation, and vasoconstriction occurs with higher doses of dopamine (3–5 μg/kg/ /min). Although the benefits of dopamine are accepted theoretically, there is not yet a consensus on its clinical use [36, 37]. Interestingly in another study, it was shown that low doses of dopamine (2 μg/kg/min) did not affect mesenteric blood flow in sheep [38]. Hiltebrand et al. demonstrated that dopamine significantly increases the cardiac index (18%), and that at doses of 5–10 μ/kg/min it increased SMA flow by 33% [39]. In one of the experimental groups in the present study, ACS first decreased splanchnic blood flow and then this was treated by dopamine infusion. Additionally, ACS-related high vascular resistance can be controlled by dopamine infusion. I/R injury is an acute inflammatory response characterized by neutrophil activation, which causes tissue damage through the production and release of cytotoxic proteins and ROMs into the extracellular area [40]. As the results of the present study show, in the groups with ACS the concentration of MDA, which is an indicator of lipid peroxidation, was higher and GSH level in the intestinal tissue was lower. This explicitly reveals that I/R injury induces oxidative stress. Intra- and extracellular lipid peroxidation in cell membranes results in tissue and organ injury. On the other hand, cells have their own defense mechanisms, called antioxidant systems. They include A, D, E and K vitamins, microelements and antioxidant molecules like MPO and GSH [41]. As part of the cellular defense system, GSH provides protection against oxidative injury [42]. It interacts with free radicals, creating more stable elements, so that the lipid peroxidation is repaired [43]. In this sense, 620 A. Saracoglu et al. GSH plays an important role as an antioxidant in limiting the propagation of free radical reactions, which would otherwise result in extensive lipid peroxidation. Tissue damage induced by various causes can result in the exhaustion of GSH [44]. In the present study, ACS significantly depleted tissue GSH stores, indicating that GSH was used as an antioxidant for the detoxification of toxic oxygen metabolites. Dopamine exerted antioxidant effects and perpetuated the cellular antioxidant mechanism, so the GSH was not entirely consumed. There are many potential sources of toxic oxygen radicals during the reperfusion period. As stated before, lipid peroxidation induced by free oxygen radicals is a possible cause of tissue injury. Moreover, the significance of circulating polymorphonuclear leukocytes as a mediator for ischemia reperfusion injury has been mentioned in previous studies [45, 46]. Various enzyme ac- tivities have been investigated in order to define the role of neutrophils in reperfusion injury. One of them is MPO, which increases more during reperfusion injury than in the ischemia period [47]. In the current study, as expected, ACS caused a significant rise in MPO activity, which indicated the contribution of neutrophil infiltration. This increase in MPO activity was inhibited in the dopamine-treated groups. ACS causes the accumulation of neutrophils in tissues, and dopamine has an inhibitory effect on the generation of free oxygen radicals. The results of the study indicate that dopamine plays a cytoprotective role in the organs with impaired intestinal blood flow. Considering the explosive increase in the use of laparoscopic surgery causing elevated IAP, along with other traumatic or surgical causes of ACS, it seems likely that low-dose dopamine infusion might be useful in critically ill patients as a free radical scavenger and a vasodilator. References [1] Cullen DJ, Coyle JP, Teprick R, Long MC: Cardiovascular, pulmonary, and renal effects of massively increased intraabdominal pressure in critically ill patients. Crit Care Med 1989, 17, 118–121. [2] Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F: Intra-abdominal hypertension in patients with severe acute pancreatitis. Critical Care 2005, 9, R452–R457. [3] Yokoyama Y, Alterman DM, Sarmadi AH, Baveja R, Zhang JX, Huynh T: Hepatic vascular response to elevated intraperitoneal pressure in the rat. J Surg Res 2002, 105, 86–94. [4] Rasmussen TE, Hallet JW, Noel AA: Early abdominal closure with mesh reduces multiple organ failure after ruptured abdominal aortic anevrysm repair. J Vasc Surg 2002, 35, 246–53. [5] Harman PK, Kron IL, McLachlan HD, Freedlender AE, Nolan SP: Elevated intra-abdominal pressure and renal function. Ann Surg 1982, 196, 594–597. [6] Eleftheriadis E, Kotzampassi K, Papanotas K, Heliadis N, Sarris K: Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg 1996, 20, 11–16. [7] Kaçmaz A, Polat A, User Y, Tilki M, Ozkan S, Sener G: Octreotide: a new approach to the management of acute abdominal hypertension. Peptides 2003, 24, 1381–1386. [8] Sener G, Paskaloglu K, Ayanoglu G: Protective effect of increasing doses of famotidine, omeprazole,lansoprazole, and melatonin against ethanol-induced gastric damage in rats. Indian J Pharmacol 2004, 36, 171–174. [9] Ishikawa F, Miyazaki S: New biodefense strategies by neutrophils. Arch Immunol Ther Exp 2005, 53, 226–233. [10] Amersi F, Nelson SK, Shen XD: Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci USA 2002, 99, 8915–8920. [11] Seo MY, Lee SM: Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/ reperfusion in rats. J Hepatol 2002, 36, 72–77. [12] Giraud GD, MacCannell KL: Decreased nutrient blood flow during dopamine and epinephrine-induced intestinal vasodilation. J Pharmacol Exp Ther 1984, 230, 214–220. [13] Lee MR: Dopamine and the kidney: ten years on. Clin Sci. 1993, 84, 357–375. [14] Ho-Lam Chung, Grace Gar-Lee Yue, Ka-Fai To, Ya-Lun Su, Yu Huang, Wing-Hung Ko: Effect of Scutellariae Radix extract on experimental dextran-sulfate sodium-induced colitis in rats. World J Gastroenterol 2007, 14, 5605–5611. [15] Drost CJ: Vessel diameter independent volume flow measurement using ultrasound: proceedings of San Diego Biomedical Symposium. San Diego, CA: San Diego Biomedical Society 1978, 17, 299–302. [16] Bradley PP, Priebat DA, Christerser RD, Rothstein G: Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982, 78, 206–209. [17] Beuge JA, Aust SD: Microsomal lipid peroxidation. Methods in Enzymology 1978, 52, 302–311. [18] Beutler E: Glutathione in red blood cell metabolism. In: A Manual of Biochemical Methods. Ed.: Beutler E, New York, NY, USA, 1979, 112–114. [19] Sener G, Kaçmaz A, User Y, Ozkan S, Tilki M, Yeğen BC: Melatonin ameliorates oxidative organ damage induced by acute intra-abdominal compartment syndrome in rats. J Pineal Res 2003, 35, 163–168. [20] Cullen DJ, Coyle JP, Teplick R, Long MC: Cardiovascular, pulmonary, and renal effects of massively increased intraabdominal pressure in critically ill patients. Crit Care Med 1989, 17, 118–121. [21] Aspesi M, Gamberoni C, Severgnini P: The abdominal compatment syndrome. Clinical relevance. Minerva Anesthesiol 2002, 68, 138–146. Dopamine in Abdominal Compartment Syndrome 621 [22] Cheatham ML: Abdominal compartment syndrome: pathophysiology and definitions. Scand J Trauma Resusc Emerg Med 2009, 17, 10. [23] Forrant JA: Understanding abdominal compartment syndrome. Nursing 2009, 39, 58–59. [24] Caldwell BC, Ricotta CC: Changes in visceral blood flow with elevated intraabdominal pressure. J Surg Res 1987, 43, 14–20. [25] Lingegowda V, Ejaz AA, Sood P: Normotensive ischemic acute kidney injury as a manifestation of intra-abdominal hypertension. Int Urol Nephrol. 2009, 41, 1043–1045. [26] Diebel LN, Myers T, Dulchavsky SA: Effects of increased airway pressure and PEEP on the assessment of cardiac preload. J Trauma 1997, 42, 585–590. [27] Barnes GE, Laine GA, Gian, PY, Smith EE, Granger HJ: Cardiovascular responses to elevation of intraabdominal hydrostatic pressure. Am J Physiol 1985, 248, 208–213. [28] Diebel LN, Wilson RF, Dulchavsky SA, Saxe J: Effect of increased intra-abdominal pressure on hepatic arterial, portal venous, and hepatic microcirculatory blood flow. J Trauma 1992, 33, 279–282. [29] Guanwen G, Pengfei W, Weiwei D, Yunzhao Z, Jieshou L: Microscopic and Ultrastructural Changes of the Intestine in Abdominal Compartment Syndrome. J Invest Surg. 2009, 22, 362–367. [30] Deenichin GP: Abdominal compartment syndrome. Surg Today 2008, 38, 5–19. [31] Blikslager AT, Roberts MC, Rhoads JM, Argenzio RA: Is reperfusion injury an important cause of mucosal damage after porcine intestinal ischemia? Surgery 1997, 121, 526–534. [32] Inotropes and Vasopressors, Review of Physiology and Clinical Use in Cardiovascular Disease. Circulation. 2008, 118, 1047–1056. [33] Tamilselvi Ramanathan: Coronary blood flow. Contin Educ Anaesth Crit Care Pain. 2005, 5, 61–64. [34] Rech MA, Prasse M, Pate G: Use of Vasopressors in Septic Shock. JCOM 2011, 18, 273–277. [35] Yeh BK, McNay JL, Goldberg LI: Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther 1969, 168, 303–309. [36] Guzman JA, Rosado AE, Kruse JA: Dopamine-1 receptor stimulation attenuates the vasoconstrictive response to gut ischemia J Appl Physiol 2001, 91, 596–602. [37] McNay JL, McDonald RH, Goldberg LI: Direct renal vasodilation produced by dopamine in the dog. Circ Res 1965, 16, 510–517. [38] Di Giantomasso D, Morimatsu H, May CN, Bellomo R: Increasing renal blood flow: low-dose dopamine or medium-dose norepinephrine. Chest 2004, 125, 2260–2267. [39] Hiltebrand LB, Krejci V, Sigurdsson GH: Effects of dopamine, dobutamine and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 2004, 100, 1188–1197. [40] Kettle AJ, Winterbourn CC: Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Report 1997, 3, 3–15. [41] Schwacha MG: Macrophages and post-burn immune dysfunction. Burns 2003, 29, 1–14. [42] Cuzzocrea S, Costantino G, Mazzon E, Micali A, de Sarro A, Caputi AP: Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 2000, 28, 52–63. [43] Sibilia V, Rindi G, Pagani F: Ghrelin protects against ethanol-induced gastric ulcers in rats: Studies on the mechanisms of action. Endocrinology 2003, 144, 353–359. [44] Paller MS, Patten M: Protective effects of glutathione, glycine, or alanine in an in vitro model of renal anoxia. J Am Soc Nephrol 1992, 2, 1338–1344. [45] Baxter GF: The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol 2002 Jul, 97, 268–275. [46] Jaeschke H: Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. AJP – GI 2006, 290, 1083–1088. [47] Grisham MB, Hernandez LA, Granger DN: Xanthine oxidase and neutrophilinfiltration in intestinal ischemia. Am J Physiol 1986, 251, 567–574. Address for correspondence: Kemal T. Saracoglu Sahrayi Cedid mah. Ataturk Cad. Yildiz Ap. No: 1 Kat: 9 Daire: 29 Erenkoy Istanbul 34734 Turkey Tel.: +90 538 547 86 20 E-mail: [email protected] Conflict of interest: None declared Received: 23.11.2011 Revised: 17.05.2011 Accepted: 5.10.2011